Polymorphs are not mythical, chimeric beasts—they are substances with identical chemical compositions but differing crystal structures that also exhibit different physical and chemical properties.

This research uncovered a previously unknown polymorph (κ-form) of indomethacin, a widely used pain relief and anti-inflammatory drug. The research team also conducted structural analysis and ...

"TAKE TWO ASPIRIN and call me in the morning," the medical adage goes. To most people, this means simply washing down two tablets. Until late 2005, "take two aspirin" didn't have any different ...

MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...

We were so pleased to have the opportunity to address InformaMarkets’ 13 th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents. Patents covering one or more crystalline ...

Crystal polymorphism, the existence of different crystal structures for the same chemical compound, is a common phenomenon in chemistry. Many compounds are known to form multiple polymorphs depending ...

MADISON, Wis.--(BUSINESS WIRE)--Breakthrough research has now revealed the true crystal forms of pharmaceutical psilocybin. A new study overcomes experimental challenges to solve the crystallographic ...

Pharmaceutical compounds often crystallize in a variety of forms known as polymorphs. Because of differences in stability, solubility, and other properties that affect the molecules’ behavior in the ...

Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...

In this interview, Dr. Matteo Daldosso, Physical Properties Unit manager at Aptuit and Dr. Sebastian Wegner, Product Manager of Solid-state NMR at Bruker Biospin, discuss novel solutions for solid ...